Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Niva...

FDA Recall #D-0001-2025 — Class II — September 24, 2024

Recall #D-0001-2025 Date: September 24, 2024 Classification: Class II Status: Ongoing

Product Description

Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.

Reason for Recall

Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.

Recalling Firm

Nivagen Pharmaceuticals Inc — Sacramento, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2328 bottles

Distribution

Nationwide within the U.S

Code Information

Lot #: U24T0408A, Exp: 03/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated